Caspases as treatment targets in stroke and neurodegenerative diseases.
about
Multiple system atrophy: cellular and molecular pathology.Plasticity in the Neonatal Brain following Hypoxic-Ischaemic InjuryInflammation and infection in clinical strokeAPSLAP: an adaptive boosting technique for predicting subcellular localization of apoptosis proteinEvidence for the involvement of Par-4 in ischemic neuron cell deathCharacterization of the rat DNA fragmentation factor 35/Inhibitor of caspase-activated DNase (Short form). The endogenous inhibitor of caspase-dependent DNA fragmentation in neuronal apoptosisInhibition of caspase-1 in rat brain reduces spontaneous nonrapid eye movement sleep and nonrapid eye movement sleep enhancement induced by lipopolysaccharideBcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the ratThe Rela(p65) subunit of NF-kappaB is essential for inhibiting double-stranded RNA-induced cytotoxicity.Sporadic amyotrophic lateral sclerosis: a hypothesis of persistent (non-lytic) enteroviral infection.Apoptosis of supraoptic AVP neurons is involved in the development of central diabetes insipidus after hypophysectomy in rats.Potent neuroprotectants linked to bifunctional inhibitionExecution of apoptosis: converging or diverging pathways?Energy requirement for caspase activation and neuronal cell death.Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease.Ischemic penumbra: evidence from functional imaging in man.Physiology of apoptosis.The pathogenesis of multiple system atrophy: past, present, and future.Caspase-1 recognizes extended cleavage sites in its natural substratesNiaspan treatment induces neuroprotection after strokeNeurobiology of hypoxic-ischemic injury in the developing brain.Mechanisms of hypoxic neurodegeneration in the developing brain.MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activityCyclin-dependent kinases and stroke.Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.Effects of the methylene chloride fraction from modified Boyang-Hwan-o-Tang, a polyherbal medicine on transient middle cerebral artery occlusion-induced ischemia in rats.NAD+ depletion or PAR polymer formation: which plays the role of executioner in ischaemic cell death?Neuroprotective effect of TAT-14-3-3ε fusion protein against cerebral ischemia/reperfusion injury in ratsCombination treatment with low-dose Niaspan and tissue plasminogen activator provides neuroprotection after embolic stroke in rats.Targeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis.Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia.Small Molecule Active Site Directed Tools for Studying Human CaspasesIschemic preconditioning protects liver from hepatectomy under hepatic inflow occlusion for hepatocellular carcinoma patients with cirrhosis.Caspase inhibitors as neuroprotective agents.Effect of Electroacupuncture on Cell Apoptosis and ERK Signal Pathway in the Hippocampus of Adult Rats with Cerebral Ischemia-Reperfusion.Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarizationReperfusion differentially induces caspase-3 activation in ischemic core and penumbra after stroke in immature brain.Hypoxic-ischemic injury in neonatal brain: involvement of a novel neuronal molecule in neuronal cell death and potential target for neuroprotectionIcaritin suppresses the proliferation of human osteosarcoma cells in vitro by increasing apoptosis and decreasing MMP expression.
P2860
Q24535446-305846FC-A399-483F-A38A-2550D573DEFCQ26751830-BAC92C94-931D-4FFF-9070-ECBCF7267CC4Q28194382-67FFF6FA-3C3D-44DD-8AFD-14E4446F2AC6Q28297448-D8E74328-9DA9-4956-9598-C627D2C99C85Q28569113-E802BC0D-BE2C-4CEE-9E07-C74BE213621EQ28577348-FA96BC54-8068-4EA1-8764-D15A8951860BQ28578834-FF91735A-67EC-4C7F-A04C-0BA24D2F0BEBQ28580390-2CBB2F5C-084B-4694-A6FE-744F88B1E48FQ31465796-4F010896-430E-4080-BF97-E684C20A8C7AQ33220088-59EF0EA7-AAF2-425D-AEF6-81A28BF5499CQ33346626-E36B7269-C72C-42C8-8CC3-C9282B5D60FCQ33732377-EA2A5F1C-3649-4723-8368-3FB9D413E681Q33763865-CABFCA63-5E99-4388-9CFD-3F868277B3A4Q33891338-C09D1350-F773-42D9-B092-673381CD89FEQ33943273-529AA00F-6234-426A-B898-9AB6708637C1Q34037705-54939E97-5A7F-4A49-9D20-0D0127261669Q34039921-1F23177C-2437-45D0-B1AA-35946C69822FQ34048136-9A7D53F1-6582-4544-96FC-AA84C26348AFQ34048288-4ADFE166-4A6A-4422-850E-93D0189F0D87Q34079520-0666929B-D1F2-4533-8469-8DD30A82495EQ34268957-637376BF-BCA0-4E77-B9E7-BE4BFCBF19A1Q34682147-D973C6C8-1DC0-427E-9C8D-D945BD37A6C5Q35045715-2C9BE960-C37B-402B-B3DF-EDAAABA65F93Q35050422-58EAF687-1B98-4958-AE15-596E11EF547EQ35083548-1A3BC926-DDED-49EB-BF97-EDBDD4D7F8D6Q35086452-4C28FA1C-A5BC-4036-8FC0-C64AA4B7ED55Q35103426-0F98DE2C-0C2A-4D0C-8672-BB1F82DB036EQ35132426-0C727284-C2CE-4007-8814-C4642593BC86Q35194742-B569CF29-96A1-4AEB-83D9-79F58AA5C0BDQ35782897-A8320D6E-B35C-444D-B2E6-2DC77B282D60Q35788051-3FCD94D1-A69A-4DAF-B8D8-4CD302C47B6BQ35809808-6D7C48C0-5E7B-4B1D-BB4E-099A1668D523Q35836079-E1B3AF26-8395-4D37-9E1F-96674AD0FE92Q36065737-626A9210-20F7-4D20-87E0-4BE54DE2AA74Q36179653-55CD6C0D-E7B7-4992-B5FA-819B45FC6DF7Q36304583-2810B1EB-3ED2-4995-99BB-F692BD01B2EBQ36342515-6F12B211-890E-4331-AB9C-08B08D9F324CQ36487445-9F8A0E1C-0EA0-4678-81D8-06CE7EF701E8Q36597093-BBB5D7AC-03C6-4C98-A84C-030DFF681AF2Q36745184-47F968F7-D71A-43C0-97B5-A8AC328E2878
P2860
Caspases as treatment targets in stroke and neurodegenerative diseases.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Caspases as treatment targets in stroke and neurodegenerative diseases.
@ast
Caspases as treatment targets in stroke and neurodegenerative diseases.
@en
type
label
Caspases as treatment targets in stroke and neurodegenerative diseases.
@ast
Caspases as treatment targets in stroke and neurodegenerative diseases.
@en
prefLabel
Caspases as treatment targets in stroke and neurodegenerative diseases.
@ast
Caspases as treatment targets in stroke and neurodegenerative diseases.
@en
P2093
P2860
P1433
P1476
Caspases as treatment targets in stroke and neurodegenerative diseases.
@en
P2093
P2860
P304
P356
10.1002/1531-8249(199904)45:4<421::AID-ANA2>3.0.CO;2-Q
P577
1999-04-01T00:00:00Z